BNP PARIBAS FINANCIAL MARKETS - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 221 filers reported holding SORRENTO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$720,158
-100.0%
812,820
-11.9%
0.00%
-50.0%
Q3 2022$1,448,273,000
+710.8%
922,467
+938.0%
0.00%
Q2 2022$178,631,000
+208.0%
88,871
+257.0%
0.00%
Q1 2022$58,005,000
-80.5%
24,895
-61.2%
0.00%
Q4 2021$298,032,000
-22.3%
64,093
+27.5%
0.00%
-100.0%
Q3 2021$383,606,000
+291.8%
50,276
+397.5%
0.00%
Q2 2021$97,917,000
-63.3%
10,105
-68.6%
0.00%
Q1 2021$266,509,000
+37.0%
32,226
+13.0%
0.00%
Q4 2020$194,594,000
-85.8%
28,512
-76.8%
0.00%
-100.0%
Q3 2020$1,367,525,000
-19.9%
122,648
-54.9%
0.00%
-33.3%
Q2 2020$1,707,268,000
+2077.8%
271,858
+538.1%
0.00%
Q1 2020$78,395,000
+29.7%
42,606
+138.2%
0.00%
Q4 2019$60,465,000
+54.5%
17,889
-2.2%
0.00%
Q3 2019$39,141,000
+1.4%
18,290
+26.5%
0.00%
Q2 2019$38,592,000
-66.7%
14,454
-40.8%
0.00%
Q1 2019$115,986,000
+688.5%
24,418
+630.4%
0.00%
Q3 2018$14,709,000
-28.1%
3,343
+17.6%
0.00%
Q2 2018$20,470,000
+2059.3%
2,843
+1084.6%
0.00%
Q1 2017$948,000
-86.4%
240
-83.2%
0.00%
Q4 2016$6,983,000
-46.2%
1,425
-15.0%
0.00%
Q3 2016$12,980,000
+106.6%
1,677
+49.5%
0.00%
Q2 2016$6,283,000
-86.9%
1,122
-79.6%
0.00%
Q4 2015$47,940,000
-2.6%
5,504
-6.1%
0.00%
Q3 2015$49,199,000
+18.3%
5,864
+148.5%
0.00%
Q2 2015$41,583,0002,3600.00%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 6,000,000$66,900,0002.57%
SABBY MANAGEMENT, LLC 606,298$6,760,0001.01%
Virtus ETF Advisers LLC 66,851$745,0000.39%
Newbridge Financial Services Group, Inc. 26,900$300,0000.30%
Avidian Wealth Solutions, LLC 330,000$3,680,0000.28%
Spectrum Wealth Advisory Group, LLC 36,692$422,0000.27%
COWEN AND COMPANY, LLC 129,200$1,441,0000.24%
Cormorant Asset Management, LP 500,000$5,575,0000.21%
SYMMETRY PEAK MANAGEMENT LLC 27,500$307,0000.20%
Aristides Capital LLC 24,302$271,0000.19%
View complete list of SORRENTO THERAPEUTICS INC shareholders